Abstract
Purpose
To formulate and characterize nanoparticles from m-7NH-m gemini surfactants, synthesized by a new improved method, for non-invasive gene delivery including optimization of composition for transfection efficiency and corneal penetration.
Methods
A one-pot, solvent-free, DMAP-free method was developed for the synthesis of m-7NH-m (m = 12–18) gemini surfactant series. Lipoplexes (LPXs) and nanoplexes (NPXs) of gemini surfactant-plasmid DNA were formulated with and without DOPE helper lipid, respectively, at various charge ratios and characterized by dynamic light scattering and zeta potential measurements. Transfection efficiency, cellular toxicity, effect of DOPE and gene expression kinetic studies were carried out in A7 astrocytes by flow cytometry and confocal microscopy. Corneal penetration studies of 18-7NH-18 NPXs were carried out using 3D EpiCorneal® tissue model.
Results
The new synthesis method provides a two-fold improved yield and the production of a pure species of m-7NH-m without DMAP and trimeric m-7N(m)-m surfactants as impurities. Structure and purity was confirmed by ESI-MS, 1H NMR spectroscopy and surface tension measurements. Particle size of 199.80 ± 1.83 nm ± S.D. and a zeta potential value of +30.18 ± 1.17 mV ± S.D. was obtained for 18-7NH-18 5:1 ratio NPXs showed optimum transfection efficiency (10.97 ± 0.11%) and low toxicity (92.97 ± 0.57% viability) at the 48-h peak expression. Inclusion of DOPE at 1: 0.5 and 1:1 ratios to gemini surfactant reduced transfection efficiency and increased toxicity. Treatment of EpiCorneal® tissue model showed deep penetration of up to 100 μm with 18-7NH-18 NPXs.
Conclusion
Overall, 18-7NH-18 NPXs are potential gene delivery systems for ophthalmic gene delivery and for further in vivo studies.
Similar content being viewed by others
Abbreviations
- CMC:
-
Critical micelle concentration
- CLSM:
-
Confocal laser scanning microscope
- DOPE:
-
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine
- DMAP:
-
4-(Dimethylamino)pyridine
- ESI-MS:
-
Electro-spray ionization mass spectrometry
- GP:
-
gemini:plasmid
- GPL:
-
gemini:plasmid:lipid
- GFP:
-
Green fluorescent protein
- 1H NMR:
-
Proton- nuclear magnetic resonance spectroscopy
- LPX:
-
Lipoplex
- NPX:
-
Nanoplex
- TE:
-
Transfection efficiency
- TFA:
-
Trifluoroacetic acid
- TIS:
-
Triisopropylsilane
- DMEM:
-
Dulbecco’s modified eagle’s medium
- FBS:
-
Fetal bovine serum
References
Bunton CA, Robinson LB, Schaak J, Stam M. Catalysis of nucleophilic substitutions by micelles of dicationic detergents. The Journal of Organic Chemistry. 1971;36(16):2346–50.
Deinega Y, Ulberg Z, Marochko L, Rudi V, Denisenko V. Investigation of colloid-chemical properties of surfactants of type of quaternary ammonium-compounds. Colloid J USSR. 1974;36(4):601–4.
Karaborni S, Esselink K, Hilbers P, Smit B, Karthauser J, Van Os N, et al. Simulating the self-assembly of gemini (dimeric) surfactants. Science. 1994;266(5183):254–6.
Menger FM, Keiper JS. Gemini surfactants. Angew Chem Int Ed. 2000;39(11):1906–20.
Kirby AJ, Camilleri P, Engberts JB, Feiters MC, Nolte RJ, Söderman O, et al. Gemini surfactants: new synthetic vectors for gene transfection. Angew Chem Int Ed. 2003;42(13):1448–57.
Badea I, Verrall R, Baca-Estrada M, Tikoo S, Rosenberg A, Kumar P, et al. In vivo cutaneous interferon-γ gene delivery using novel dicationic (gemini) surfactant-plasmid complexes. The journal of gene medicine. 2005;7(9):1200–14.
Wang C, Li X, Wettig SD, Badea I, Foldvari M, Verrall RE. Investigation of complexes formed by interaction of cationic gemini surfactants with deoxyribonucleic acid. Phys Chem Chem Phys. 2007;9(13):1616–28.
Wettig SD, Verrall RE, Foldvari M. Gemini surfactants: a new family of building blocks for non-viral gene delivery systems. Current gene therapy. 2008;8(1):9–23.
Ahmed T, Kamel AO, Wettig SD. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I. Nanomedicine. 2016;11(3):289–306.
Muñoz-Úbeda M, Misra SK, Barrán-Berdón AL, Datta S, Aicart-Ramos C, Castro-Hartmann P, et al. How does the spacer length of cationic Gemini lipids influence the Lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy. Biomacromolecules. 2012;13(12):3926–37.
Wettig S. D., Badea I, Donkuru M, Verrall RE, Foldvari M. structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles. J Gene Med. 2007;9(8):649–58.
Wettig SD, Wang C, Verrall RE, Foldvari M. Thermodynamic and aggregation properties of aza- and imino-substituted gemini surfactants designed for gene delivery. Phys Chem Chem Phys. 2007;9(7):871–7.
Donkuru M, Wettig SD, Verrall RE, Badea I, Foldvari M. Designing pH-sensitive gemini nanoparticles for non-viral gene delivery into keratinocytes. J Mater Chem. 2012;22(13):6232–44.
Al-Dulaymi M, Michel D, Chitanda JM, El-Aneed A, Verrall RE, Grochulski P, et al. Molecular engineering as an approach to modulate gene delivery efficiency of peptide-modified Gemini surfactants. Bioconjug Chem. 2018;29(10):3293–308.
Mohammed-Saeid W, Chitanda J, Al-Dulaymi M, Verrall R, Badea I. Design and evaluation of RGD-modified Gemini surfactant-based Lipoplexes for targeted gene therapy in melanoma model. Pharm Res. 2017;34(9):1886–96.
Singh J, Yang P, Michel D, Verrall RE, Foldvari M, Badea I. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents. Current drug delivery. 2011;8(3):299–306.
Yang P, Singh J, Wettig S, Foldvari M, Verrall RE, Badea I. Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2010;75(3):311–20.
Menger FM, Littau CA. Gemini-surfactants: synthesis and properties. J Am Chem Soc. 1991;113(4):1451–2.
Menger FM, Littau CA. Gemini surfactants: a new class of self-assembling molecules. J Am Chem Soc. 1993;115(22):10083–90.
Zana R, Benrraou M, Rueff R. Alkanediyl-a, w-bis (dimethyl-alkyl ammonium bromide) surfactants. 1. Effect of the spacer chain length on the CMC and micelle ionization degree. Langmuir : the ACS journal of surfaces and colloids. 1991;7:1072–5.
Wettig SD, Verrall RE. Thermodynamic studies of aqueous m–s–m Gemini surfactant systems. J Colloid Interface Sci. 2001;235(2):310–6.
Elsabahy M, Badea I, Verrall R, Donkuru M, Foldvari M. Dicationic gemini nanoparticle design for gene therapy. In: John Wiley & Sons, Inc; 2013. p. 509–528.
Hayashi Y. Pot economy and one-pot synthesis. Chem Sci. 2016;7(2):866–80.
Raju M, Mäeorg S, Tšubrik O, Mäeorg U. Efficient solventless technique for Boc-protection of hydrazines and amines. Arkivoc. 2009;6:291–7.
Han Y, Wang Y. Aggregation behavior of gemini surfactants and their interaction with macromolecules in aqueous solution. Phys Chem Chem Phys. 2011;13(6):1939–56.
Zana R. Dimeric (Gemini) surfactants: effect of the spacer group on the association behavior in aqueous solution. J Colloid Interface Sci. 2002;248(2):203–20.
Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release. 2002;78(1):259–66.
Buck J, Grossen P, Cullis PR, Huwyler J, Witzigmann D. Lipid-based DNA therapeutics: hallmarks of non-viral gene delivery. ACS Nano. 2019;13(4):3754–82.
Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther. 1997;8(13):1585–94.
Audouy S, Molema G, de Leij L, Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. The Journal of Gene Medicine: A cross-disciplinary journal for research on the science of gene transfer and its clinical applications. 2000;2(6):465–76.
Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent Progress. AAPS J. 2009;11(4):671.
Beddoes CM, Case CP, Briscoe WH. Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interf Sci. 2015;218:48–68.
Munro S. Lipid rafts: elusive or illusive? Cell. 2003;115(4):377–88.
Taheri-Araghi S, Chen D-W, Kohandel M, Sivaloganathan S, Foldvari M. Tuning optimum transfection of gemini surfactant–phospholipid–DNA nanoparticles by validated theoretical modeling. Nanoscale. 2019;11(3):1037–46.
Gharagozloo M, Rafiee A, Chen DW, Foldvari M. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation. Journal of Nanobiotechnology. 2015;13(1):62.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editor: Sheng Qi
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Narsineni, L., Foldvari, M. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro. Pharm Res 37, 144 (2020). https://doi.org/10.1007/s11095-020-02836-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-020-02836-6